Anabolic Protocol
Maximum muscle growth, strength gains, and anabolic signalling
Peptide Stack
Preparation
Reconstitute all peptides with bacteriostatic water. CJC-1295 and Ipamorelin can be mixed. IGF-1 LR3 should be kept separate. Store at 2-8°C and use within 2-4 weeks.
Administration
Morning: CJC/Ipa (fasted). Post-workout: IGF-1 LR3. Before bed: CJC/Ipa. All subcutaneous injections. Rotate sites. Maintain high protein intake and progressive overload training.
Monitoring
Track body weight, strength levels, muscle measurements, and workout performance weekly. Take progress photos. Most users see strength gains by week 2-3, visible muscle growth by week 4-6.
Expected Timeline
Week 1-2: Enhanced recovery and strength. Week 3-6: Noticeable muscle growth and performance gains. Week 7-10: Continued anabolic effects and body recomposition. Best results with proper training and nutrition.
Research Basis
CJC/Ipa elevates growth hormone for overall anabolic environment. IGF-1 LR3 provides sustained, direct anabolic signalling to muscle tissue with extended half-life. Together, they maximize muscle protein synthesis.
Safety Considerations
- Do not use if you have active cancer
- Avoid during pregnancy or breastfeeding
- Monitor blood glucose levels
- Ensure adequate protein intake (1.6-2.2g per kg bodyweight)
- Consult with a healthcare professional before starting
- This protocol is for research and educational purposes only
Protocol Overview
An advanced muscle-building protocol combining GH optimization with IGF-1 LR3 for maximum anabolic signaling. The CJC/Ipa base elevates GH while IGF-1 LR3 provides sustained, direct anabolic drive to muscle tissue.
Duration: 10 weeks Peptides: 3 Experience Level: Beginner
Peptide Stack
CJC-1295-NO-DAC
- Dose: 100 mcg
- Frequency: twice daily
- Timing: morning and before bed
IPAMORELIN
- Dose: 100-200 mcg
- Frequency: twice daily
- Timing: with CJC-1295 doses
IGF-1-LR3
- Dose: 40-80 mcg
- Frequency: daily
- Timing: post-workout or morning
Preparation
Reconstitute all peptides with bacteriostatic water. CJC-1295 and Ipamorelin can be mixed. IGF-1 LR3 should be kept separate. Store at 2-8°C and use within 2-4 weeks.
Administration
Morning: CJC/Ipa (fasted). Post-workout: IGF-1 LR3. Before bed: CJC/Ipa. All subcutaneous injections. Rotate sites. Maintain high protein intake and progressive overload training.
Monitoring
Track body weight, strength levels, muscle measurements, and workout performance weekly. Take progress photos. Most users see strength gains by week 2-3, visible muscle growth by week 4-6.
Expected Timeline
Week 1-2: Enhanced recovery and strength. Week 3-6: Noticeable muscle growth and performance gains. Week 7-10: Continued anabolic effects and body recomposition. Best results with proper training and nutrition.
Research Basis
CJC/Ipa elevates growth hormone for overall anabolic environment. IGF-1 LR3 provides sustained, direct anabolic signalling to muscle tissue with extended half-life. Together, they maximize muscle protein synthesis.
Safety Considerations
- Do not use if you have active cancer
- Avoid during pregnancy or breastfeeding
- Monitor blood glucose levels
- Ensure adequate protein intake (1.6-2.2g per kg bodyweight)
- Consult with a healthcare professional before starting
- This protocol is for research and educational purposes only
Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.
Important Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.